US Patent Issued to CLARITY PHARMACEUTICALS on March 3 for "Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals" (Australian Inventors)

ALEXANDRIA, Va., March 3 -- United States Patent no. 12,565,506, issued on March 3, was assigned to CLARITY PHARMACEUTICALS LTD (Eveleigh, Australia).

"Nitrogen-containing macrocyclic conjugates as radiopharmaceuticals" was invented by Paul Stephen Donnelly (Victoria, Australia), Michelle Therese Ma (Victoria, Australia) and Denis Bernard Scanlon (Meadows, Australia).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to compounds that are useful as metal ligands and which either contain a molecular recognition moiety or can be bound to a molecular recognition moiety and methods of making these compounds. Once the compounds that contain a molecular recognition moiety are coordinated w...